Veranova

Veranova is pleased to announce that it is expanding its Advisory Board with the appointment of Dr Rajni A. and Dr Brad L. Pentelute. As members of our Advisory Board, Rajni and Brad will provide expert strategic and scientific guidance to support our vision of becoming the global leader in complex API development and manufacturing. We are looking forward to working with them and gaining insights from their wide-ranging expertise as we continue to advance our global strategy and capabilities to support the commercialization of life-saving therapeutics. Read the full press release to learn more: https://lnkd.in/eEMn2aRz

For our second #PharmorphixFix post, we are hearing from Veranova’s Senior Scientist, Cristina M. Balogh, and Principal Scientist, Thierry Bonnaud. Find out below how our Pharmorphix team used their salt and cocrystal screening expertise to rationally select a less-common counterion suitable for creating an API salt with improved stability and solubility. You can also watch our latest webinar to learn more about the project and hear the full case study: https://lnkd.in/gHcQumQ5

#DYK that 1 in 5 #SmallMolecule drugs approved by FDA since 2014 have leveraged Veranova technology? At Veranova, we help accelerate #DrugDevelopment projects by leveraging our longstanding expertise and technology, while working closely with our customers to develop more efficient, scaled-up processes. Learn more: https://veranova.com

The Veranova team are looking forward to being in Italy next week for CPHI Milan. If you’re also attending, make sure to visit our experts at Stand 5A105 to learn more about how we can apply our expertise and capabilities to accelerate your complex API development and manufacturing project.  Get in touch to book a meeting with the team: https://lnkd.in/gqDcGEPT

We recently released a new webinar focused on techniques for enhancing API solubility. In the webinar, Veranova's Senior Scientist, Cristina M. Balogh, presents a case study explaining how our solid form and particle engineering team developed a new crystalline salt of Edaravone Edisylate, the API in the amyotrophic lateral sclerosis (ALS) medication Edaravone. Watch the full webinar to learn more about the project and our solid form and particle engineering capabilities: https://lnkd.in/gHcQumQ5

The Veranova teams at both of our UK sites in Edinburgh and Cambridge recently held #MacmillanCoffeeMorning events to fundraise for Macmillan Cancer Support. Together, our teams raised over £2,000 which will go towards supporting Macmillan’s mission of helping people whose lives are affected by cancer. We are extremely proud of this achievement which wouldn’t have been possible without our team’s dedication and generosity. Take a look below to see some photos from the events and find out more about Macmillan's work: https://lnkd.in/gmfbxP7

We’re excited to launch our new series, #PharmorphixFix! Over the coming weeks, we will be sharing insights from Veranova’s solid form and particle engineering brand, Pharmorphix®. In each post, we’ll explain how we’ve supported clients through the drug development process and highlight our key achievements along the way. Each story will focus on a real-world challenge we’ve solved for our clients, showcasing the expertise we applied to manage complexity with confidence. This week, we hear from Carrie Sheard, Senior Scientist II, Analytical Solid Form, as she explains how our teams worked together to identify the optimal salt form of an API from several promising options. Read the full #PharmorphixFix case study below and learn more about our solid form screening services: https://lnkd.in/gCn466H2

We’re back with another #MeetVeranova spotlight! This week, we’re introducing Michael Bease, Manufacturing Manager at our site in Edinburgh, UK. With over 20 years of experience at Veranova, Mike plays a vital role in ensuring the safe and compliant production of active pharmaceutical ingredients. Learn more about Mike’s work below and find out how he collaborates with teams across the site to support the delivery of life-changing treatments to patients. 

Are you interested in finding out how Veranova can support your drug development and manufacturing project? Watch our video below to hear from our CEO, Mike Riley, who outlines our expertise in advancing products that require complex synthesis and special handling capabilities from pre-clinical development to commercialization. If you’re attending CPHI Milan, you can also visit our team in-person at Stand 5A105. Get in touch now to book a meeting with our experts and discover how we can help you manage complexity with confidence: https://lnkd.in/gqDcGEPT

Last week, our New England teams at Devens and North Andover, MA took part in their annual Safety and Quality Day! During the day, our teams were visited by a series of guest speakers and participated in a range of interactive sessions based on this year’s theme: “Safety first, Quality always!”. See some highlights from the day below and visit our website to learn more about our commitment to ensuring the wellbeing of our team and protecting the safety of patients around the world: https://lnkd.in/ejpbFAd9